Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-24 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −15,000 $42.00 $630K 88,787
2025-12-24 Inrig Jula CHIEF MEDICAL OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −15,000 76,000
2025-12-24 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −7,402 $40.00 $296K 38,233
2025-12-24 Heerma Peter CHIEF COMMERCIAL OFFICER Sale 10b5-1 −4,980 $40.00 $199K 113,013
2025-12-24 ROTE WILLIAM E. Chief Research Officer Option exercise 10b5-1 +60,000 $20.61 $1.2M 161,443
2025-12-24 ROTE WILLIAM E. Chief Research Officer Sale 10b5-1 −60,000 $40.10 $2.4M 101,443
2025-12-24 ROTE WILLIAM E. Chief Research Officer Option exercise · Employee stock option (right to buy) 10b5-1 −60,000 0
2025-12-15 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −2,910 $36.00 $105K 45,635
2025-12-01 Cline Christopher R. CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +20,000 $16.23 $325K 112,083
2025-12-01 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −20,000 $35.01 $700K 92,083
2025-12-01 Cline Christopher R. CHIEF FINANCIAL OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −20,000 0
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +10,000 $25.25 $253K 64,410
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +17,500 $26.88 $470K 81,910
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +15,000 $27.50 $413K 96,910
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +12,500 $22.40 $280K 109,410
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +6,250 $8.93 $56K 115,660
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −67,115 $36.00 $2.4M 48,545
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 0
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −17,500 0
2025-11-04 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −15,000 2,500

Page 15 of 51 · 1,020 trades